Home » Newsletters » BioWorld

BioWorld

Oct. 25, 2001

View Archived Issues

Other News To Note

Xenon Adds Discovery Capability Through QuantaNova Purchase

OSI Starts Two More Phase III Trials Of Growth-Factor Drug

Abbott Buying Vysis In $355M Cash Deal, A 33 Percent Premium

Affymetrix, Millennium Enter GeneChip Development Deal

Drugs To Bust Bacterial Biofilm, Cesspit of Antibiotic Resistance, Rampant Infection, Sought Now